Completed PHASE4 INTERVENTIONAL 2-arm NCT01632371

Intracoronary Stenting and Angiographic Results: Optimizing Treatment of Drug Eluting Stent In-Stent Restenosis 4 (ISAR-DESIRE 4)

ISAR-DESIRE 4: Randomized Trial Of Scoring Balloon in Patients With Restenosis in Limus-Eluting Coronary Stents Undergoing Angioplasty With Paclitaxel-Coated Balloon

Sponsor: Biotronik AG

Conditions Acute Coronary Syndrome Restenosis Stable Angina Pectoris

Interventions Paclitaxel Eluting Balloon Paclitaxel Eluting Balloon + Scoring Balloon

Updated 5 times since 2017 Last updated: Nov 18, 2016 Started: Jun 30, 2012 Primary completion: Aug 31, 2015 Completion: Nov 30, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01632371, this PHASE4 trial focuses on Acute Coronary Syndrome and Restenosis and remains completed. Sponsored by Biotronik AG, it has been updated 5 times since 2012, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Jun 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Biotronik AG
Deutsches Herzzentrum Muenchen

Data source: Deutsches Herzzentrum Muenchen

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Munich, Germany